Skip to main content

Advertisement

Log in

Bevacizumab for treatment of choroidal neovascularization secondary to candida chorioretinitis

  • Case Report
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To report a case of juxtafoveal choroidal neovascularization in a patient with candida chorioretinitis successfully treated with intravitreal bevacizumab.

Methods

Case report.

Results

A 45-year-old woman previously treated for candida chorioretinitis was presented with reduced vision in the left eye. The patient was investigated with ophthalmoscopy, fluorescein angiography, and optical coherence tomography (OCT). Following initial treatment, fundus examination, fluorescein angiography, and OCT of the right eye revealed a secondary juxtafoveal classic choroidal neovascularization. Following a single intravitreal injection of bevacizumab, the patient had excellent visual recovery, with absence of subretinal or intraretinal fluid in the OCT.

Conclusions

Bevacizumab was effective in treatment of choroidal neovascularization associated with candida chorioretinitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Lashof AMO, Rothova A, Sobel JD, Ruhnke M, Pappas PG, Viscoli C, Schlamm HT, Oborska IT, Rex JH, Kullberg BJ (2011) Ocular manifestations of candidemia. Clin Infect Dis 53(3):262–268. doi:10.1093/cid/cir355

    Article  Google Scholar 

  2. Shah CP, McKey J, Spirn MJ, Maguire J (2008) Ocular candidiasis: a review. Br J Ophthalmol 92(4):466–468. doi:10.1136/bjo.2007.133405

    Article  CAS  PubMed  Google Scholar 

  3. Jampol LM, Sung J, Walker JD, Folk JC, Townsend-Pico WA, Lowder CY, Dodds EM, Westrich D, Terry J (1996) Choroidal neovascularization secondary to Candida albicans chorioretinitis. Am J Ophthalmol 121(6):643–649

    Article  CAS  PubMed  Google Scholar 

  4. Macular Photocoagulation Study Group (1994) Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Arch Ophthalmol 112(4):500–509

    Article  Google Scholar 

  5. Tedeschi M, Varano M, Lomoriello DS, Scassa C, Parisi V (2007) Photodynamic therapy outcomes in a case of macular choroidal neovascularization secondary to Candida endophthalmitis. Eur J Ophthalmol 17(1):124–127

    Article  CAS  PubMed  Google Scholar 

  6. Recchia FM, Shah GK, Eagle RC, Sivalingam A, Fischer DH (2002) Visual and anatomical outcome following submacular surgery for choroidal neovascularization secondary to Candida endophthalmitis. Retina 22(3):323–329

    Article  PubMed  Google Scholar 

  7. Durand ML (2013) Endophthalmitis. Clin Microbiol Infect 19(3):227–234. doi:10.1111/1469-0691.12118

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Sallam A, Taylor SR, Khan A, McCluskey P, Lynn WA, Manku K, Pacheco PA, Lightman S (2012) Factors determining visual outcome in endogenous Candida endophthalmitis. Retina 32(6):1129–1134. doi:10.1097/IAE.0b013e31822d3a34

    Article  PubMed  Google Scholar 

  9. Doan T, Vemulakonda GA, Choi D, Keene CD, Akileswaran L, Van Gelder RN, Chao JR (2014) Retinal neovascularization and endogenous fungal endophthalmitis in intravenous drug users. Ophthalmology 121(9):1847–1848. doi:10.1016/j.ophtha.2014.03.037

    Article  PubMed  PubMed Central  Google Scholar 

  10. Dhingra N, Kelly S, Majid MA, Bailey CB, Dick AD (2010) Inflammatory choroidal neovascular membrane in posterior uveitis-pathogenesis and treatment. Indian J Ophthalmol 58(1):3–10. doi:10.4103/0301-4738.58467

    Article  PubMed  PubMed Central  Google Scholar 

  11. Coats ML, Peyman GA (1992) Intravitreal corticosteroids in the treatment of exogenous fungal endophthalmitis. Retina 12(1):46–51

    Article  CAS  PubMed  Google Scholar 

  12. Shimada H, Yuzawa M, Hirose T, Nakashizuka H, Hattori T, Kazato Y (2008) Pathological findings of multifocal choroiditis with panuveitis and punctate inner choroidopathy. Jpn J Ophthalmol 52(4):282–288. doi:10.1007/s10384-008-0566-2

    Article  PubMed  Google Scholar 

  13. Carreno E, Moutray T, Fotis K, Lee RW, Dick AD, Ross AH, Bailey C (2015) Phase IIb clinical trial of ranibizumab for the treatment of uveitic and idiopathic choroidal neovascular membranes. Br J Ophthalmol. doi:10.1136/bjophthalmol-2015-307806

    PubMed  Google Scholar 

  14. Tian JX, O’Hagan S (2015) Toxocara polymerase chain reaction on ocular fluids in bilateral granulomatous chorioretinitis. Int Med Case Rep J 8:107–110. doi:10.2147/IMCRJ.S84185

    Article  PubMed  PubMed Central  Google Scholar 

  15. Lyall DA, Hutchison BM, Gaskell A, Varikkara M (2010) Intravitreal ranibizumab in the treatment of choroidal neovascularisation secondary to ocular toxocariasis in a 13-year-old boy. Eye (Lond) 24(11):1730–1731. doi:10.1038/eye.2010.131

    Article  CAS  Google Scholar 

  16. Kianersi F, Naderi Beni A, Naderi Beni Z, Ghanbari H (2015) Intravitreal bevacizumab for treatment of choroidal neovascularization secondary to toxoplasmic retinochoroiditis: a case series. Semin Ophthalmol 30(3):181–187. doi:10.3109/08820538.2013.838278

    Article  PubMed  Google Scholar 

  17. Sheu SJ (2009) Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to endogenous endophthalmitis. Kaohsiung J Med Sci 25(11):617–621. doi:10.1016/S1607-551X(09)70566-2

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

RWJL and ADD received funding from the National Institute for Health Research (NIHR) Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ester Carreño.

Ethics declarations

Conflicts of interest

None of the authors have any proprietary interest in the materials described in this study.

Ethical standard

This report is limited to secondary use of information previously collected in the course of normal care (without an intention to use it for research at the time of collection) and therefore excluded from REC review.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Makragiannis, G., Vahdani, K., Carreño, E. et al. Bevacizumab for treatment of choroidal neovascularization secondary to candida chorioretinitis. Int Ophthalmol 38, 781–785 (2018). https://doi.org/10.1007/s10792-017-0502-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-017-0502-x

Keywords

Navigation